IRCT20190711044175N1RecruitingPhase 1
Cell therapy using human endometrial stem cell(hEnSCs) in patients with Secondary progressive-MS(SPMS): Phase I clinical trial
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 45 years (—)
- Sex
- Female
Inclusion Criteria
- •(1)Women with SPMS who did not respond to their disease-modifying therapies .
- •(2) Age between 18–45 years
- •(3) EDSS less than 5.5
- •(4) Disease duration of 2 - 15 years..
- •(5) Women with at least one delivery
- •(6) Women who are taking Rituximab drugs
Exclusion Criteria
- •Women under the age of 18 and over 45 years
- •Pregnant patients
- •Patients with positive results from screening tests for hepatitis B and C, human immunode?ciency virus (HIV), and human T-cell lymphotropic virus (HTLV) were also excluded from the study.
- •Patients who had used cytotoxic agents or hormonal therapy within 3 months prior to the study .
- •Patients with endometriosis and other uterine problems
Investigators
Similar Trials
Recruiting
Phase 1
Cell Therapy in Women's HealthStress urinary incontinenceC12.777.934.852.249RBR-29x2prniversidade Federal de São Paulo
Completed
Phase 4
Obtaining uterine stem cells from postmenopausal women undergoing hysterectomy.ACTRN12610000563066Professor CAroline Gargett15
Unknown
Phase 1
Clinical Safety Study of Human Embryonic Stem Cell Derived Mesenchymal Cells in the Treatment of Moderate and Severe Intrauterine AdhesionsIntrauterine AdhesionNCT04232592Qi Zhou32
Completed
Not Applicable
Edessy Stem Cell Score (ESS), Endometrium, EndometriomaEndometriosis, OvarianNCT02103452Al-Azhar University80
Recruiting
Phase 2
Isolation , Purification, Characterization and Commercialization of Stem Cells From Fetal Membrane layers and Their Use for the Treatment of Patients With Acute Respiratory Distress Syndrome (ARDS)Acute Respiratory Distress Syndrome.Acute Respiratory Distress SyndromeIRCT2017010531786N1Breast Cancer Research Center (BCRC), Motamed Cancer Institute, Tehran University of Medical science15
